Private company

Artal International S.C.A.

Last updated Oct 21, 2026.

Overview

See how the biggest companies compare on our leaderboards

Corporate structure

Artal International S.C.A. sits at the top of its group. 30 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Artal International S.C.A.
- Achilles Therapeutics plc Stake · Birmingham, United Kingdom
- Agenus Stake · Lexington, Massachusetts, United States
- Ambrx Biopharma Cayman, Inc. Stake · La Jolla, California
- Aptinyx Inc. Stake · Evanston, Illinois
- Aravive, Inc. Stake · Menlo Park, California, United States
- BELLUS Health Inc. Stake · Laval, Canada
- Cava Group Stake · Washington, D.C.
- CRESCENT BIOPHARMA, INC. Stake · Waltham, Massachusetts
- CYPHERPUNK TECHNOLOGIES INC. Stake · Cambridge, Massachusetts
- Generation Bio Co. Stake · Cambridge, Massachusetts
- Gossamer Bio, Inc. Stake · San Diego, California, United States
- Harpoon Therapeutics, Inc. Stake · South San Francisco, California, United States
- HOOKIPA Pharma Inc. Stake · New York, New York
- IGM Biosciences, Inc. Stake · Mountain View, California, United States
- Kalaris Therapeutics, Inc. Stake · Berkeley Heights, New Jersey
- Korro Bio, Inc. Stake · Cambridge, Massachusetts
- Korsana Biosciences, Inc. Stake · Waltham, Massachusetts
- Morphic Holding, Inc. Stake · Waltham, Massachusetts, United States
- Nanobiotix S.A. Stake · I0
- NexImmune, Inc. Stake · Gaithersburg, Maryland, United States
- Omega Alpha SPAC Stake · Boston, Massachusetts
- Scholar Rock Holding Corp Stake · Cambridge, Massachusetts, United States
- Seer, Inc Stake · Redwood City
- Selecta Biosciences (United States) Stake · Watertown, Massachusetts, United States
- Silence Therapeutics Stake · London, United Kingdom
- and 4 more

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (29 companies). Each entity in the chart links to its source.

Filings

22 filings to the SEC since October 2021: 22 other. The latest 20:

Aug 24, 2026N-PX EDGAR
Aug 13, 202613F-NT EDGAR
May 14, 202613F-NT EDGAR
Feb 12, 202613F-NT EDGAR
Nov 12, 202513F-NT EDGAR
Aug 28, 2025N-PX EDGAR
Aug 13, 202513F-NT EDGAR
May 14, 202513F-NT EDGAR
Feb 14, 202513F-NT EDGAR
Nov 13, 202413F-NT EDGAR
Aug 14, 202413F-NT EDGAR
May 13, 202413F-NT EDGAR
Feb 9, 202413F-NT EDGAR
Nov 13, 202313F-NT EDGAR
Aug 11, 202313F-NT EDGAR
May 12, 202313F-NT EDGAR
Feb 13, 202313F-NT EDGAR
Nov 14, 202213F-NT EDGAR
Aug 11, 202213F-NT EDGAR
May 12, 202213F-NT EDGAR

The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Artal International S.C.A. has told the SEC it owns more than 5% of 29 companies, latest first (Schedules 13D and 13G).

Cava GroupSCHEDULE 13G/A Feb 9, 2024 to Aug 13, 2026²
Korro Bio, Inc.SC 13G/A Nov 13, 2023 to Jul 12, 2024³
Korsana Biosciences, Inc.SC 13G/A Feb 11, 2022 to Jul 12, 2024⁴
Selecta Biosciences (United States)SC 13G/A Jun 12, 2023 to Jul 12, 2024⁵
HOOKIPA Pharma Inc.SC 13G Jul 8, 2024⁶
Achilles Therapeutics plcSC 13G/A Feb 13, 2023 to Mar 29, 2024⁷
Vigil Neuroscience, Inc.SC 13G/A Aug 23, 2022 to Mar 29, 2024⁸
AgenusSC 13G/A Feb 1, 2023 to Feb 9, 2024⁹
Ambrx Biopharma Cayman, Inc.SC 13G/A Feb 13, 2023 to Feb 9, 2024¹⁰
Aptinyx Inc.SC 13G/A Feb 13, 2023 to Feb 9, 2024¹¹
Aravive, Inc.SC 13G/A Feb 13, 2023 to Feb 9, 2024¹²
CRESCENT BIOPHARMA, INC.SC 13G/A Feb 13, 2023 to Feb 9, 2024¹³
Harpoon Therapeutics, Inc.SC 13G/A Mar 31, 2023 to Feb 9, 2024¹⁴
IGM Biosciences, Inc.SC 13G/A Feb 11, 2022 to Feb 9, 2024¹⁵
Kalaris Therapeutics, Inc.SC 13G/A Aug 5, 2022 to Feb 9, 2024¹⁶
Morphic Holding, Inc.SC 13G/A Feb 11, 2022 to Feb 9, 2024¹⁷
Nanobiotix S.A.SC 13G/A Feb 11, 2022 to Feb 9, 2024¹⁸
SQZ Biotechnologies CoSC 13G/A Feb 13, 2023 to Feb 9, 2024¹⁹
Scholar Rock Holding CorpSC 13G/A Feb 11, 2022 to Feb 9, 2024²⁰
Silence TherapeuticsSC 13G/A Sep 1, 2023 to Feb 9, 2024²¹
Syros Pharmaceuticals, Inc.SC 13G/A Feb 11, 2022 to Feb 9, 2024²²
Solid Biosciences Inc.SC 13G Jan 22, 2024²³
Gossamer Bio, Inc.SC 13G Jan 11, 2024²⁴
BELLUS Health Inc.SC 13G/A Feb 11, 2022 to Feb 13, 2023²⁵
NexImmune, Inc.SC 13G/A Feb 13, 2023²⁶
Omega Alpha SPACSC 13G/A Feb 13, 2023²⁷
CYPHERPUNK TECHNOLOGIES INC.SC 13G/A Feb 11, 2022²⁸
Generation Bio Co.SC 13G/A Feb 11, 2022²⁹
Seer, IncSC 13G/A Feb 11, 2022³⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArtal International S.C.A. filings on SEC EDGAR
2
SEC EDGARArtal International S.C.A. SCHEDULE 13G/A on Cava Group
3
SEC EDGARArtal International S.C.A. SC 13G/A on Korro Bio, Inc.
4
SEC EDGARArtal International S.C.A. SC 13G/A on Korsana Biosciences, Inc.
5
SEC EDGARArtal International S.C.A. SC 13G/A on Selecta Biosciences (United States)
6
SEC EDGARArtal International S.C.A. SC 13G on HOOKIPA Pharma Inc.
7
SEC EDGARArtal International S.C.A. SC 13G/A on Achilles Therapeutics plc
8
SEC EDGARArtal International S.C.A. SC 13G/A on Vigil Neuroscience, Inc.
9
SEC EDGARArtal International S.C.A. SC 13G/A on Agenus
10
SEC EDGARArtal International S.C.A. SC 13G/A on Ambrx Biopharma Cayman, Inc.
11
SEC EDGARArtal International S.C.A. SC 13G/A on Aptinyx Inc.
12
SEC EDGARArtal International S.C.A. SC 13G/A on Aravive, Inc.
13
SEC EDGARArtal International S.C.A. SC 13G/A on CRESCENT BIOPHARMA, INC.
14
SEC EDGARArtal International S.C.A. SC 13G/A on Harpoon Therapeutics, Inc.
15
SEC EDGARArtal International S.C.A. SC 13G/A on IGM Biosciences, Inc.
16
SEC EDGARArtal International S.C.A. SC 13G/A on Kalaris Therapeutics, Inc.
17
SEC EDGARArtal International S.C.A. SC 13G/A on Morphic Holding, Inc.
18
SEC EDGARArtal International S.C.A. SC 13G/A on Nanobiotix S.A.
19
SEC EDGARArtal International S.C.A. SC 13G/A on SQZ Biotechnologies Co
20
SEC EDGARArtal International S.C.A. SC 13G/A on Scholar Rock Holding Corp
21
SEC EDGARArtal International S.C.A. SC 13G/A on Silence Therapeutics
22
SEC EDGARArtal International S.C.A. SC 13G/A on Syros Pharmaceuticals, Inc.
23
SEC EDGARArtal International S.C.A. SC 13G on Solid Biosciences Inc.
24
SEC EDGARArtal International S.C.A. SC 13G on Gossamer Bio, Inc.
25
SEC EDGARArtal International S.C.A. SC 13G/A on BELLUS Health Inc.
26
SEC EDGARArtal International S.C.A. SC 13G/A on NexImmune, Inc.
27
SEC EDGARArtal International S.C.A. SC 13G/A on Omega Alpha SPAC
28
SEC EDGARArtal International S.C.A. SC 13G/A on CYPHERPUNK TECHNOLOGIES INC.
29
SEC EDGARArtal International S.C.A. SC 13G/A on Generation Bio Co.
30
SEC EDGARArtal International S.C.A. SC 13G/A on Seer, Inc